For the Inventor, By the Inventor

Enter inventor name

New York, NY, United States of America

David Frendewey

USPTO Granted Patents = 56 (Patent Applications = 25)

CIPO Patents = 12 (Patent Applications = 16)

EPO Patents = 21 (Patent Applications = 33)

Average Co-Inventor Count = 5.3

ph-index = 11

Forward Citations = 689(Granted Patents)

Forward Citations (Not Self Cited) = 496(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

54 out of 1,343

Regeneron Pharmaceuticals, Inc.

Regeneran Pharmaceuticals, Inc.

Harvard College

where one patent can have more than one assignee

Years Active: 2007-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Tauopathy Models

Antigen-Binding Proteins

Genetic Modification

Fertile XY Female Animals

Humanized TTR Locus

CRISPR/Cas Technology

Nuclease-Mediated Targeting

Mouse Embryonic Stem Cells

Tumor Cell Response Markers

Differentiation-Dependent Self-Deleting Cassette

Homologous Recombination

IncRNA-Knockout Mice

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391920 - Models of tauopathy (2025-08-19),

2. 12342801 - Methods for producing antigen-binding proteins against foreign antigens (2025-07-01),

3. 12110502 - Models of tauopathy (2024-10-08),

4. 12065661 - Genetic modification of rats (2024-08-20),

5. 12060571 - Methods and compositions for modifying a targeted locus (2024-08-13),

6. 12041918 - Production of fertile XY female animals by silencing of genes on the Y chromosome (2024-07-23),

7. 12010979 - Non-human animals comprising a humanized TTR locus and methods of use (2024-06-18),

8. 11891618 - Mouse comprising a humanized TTR locus with a beta-slip mutation and methods of use (2024-02-06),

9. 11845957 - Models of tauopathy (2023-12-19),

10. 11820997 - Methods and compositions for the targeted modification of a genome (2023-11-21),

11. 11697828 - Methods and compositions for targeted genetic modification using paired guide RNAs (2023-07-11),

12. 11690362 - Nuclease-mediated repeat expansion (2023-07-04),

13. 11547100 - Method for screening gene expression in lincRNA-deficient mice or rats (2023-01-10),

14. 11021719 - Methods and compositions for assessing CRISPER/Cas-mediated disruption or excision and CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo (2021-06-01),

15. 10894965 - Genetic modification of rats (2021-01-19),

Title: The Innovative Mind of David Frendewey

Introduction: David Frendewey is a renowned inventor based in New York, NY, known for his groundbreaking contributions to various industries.

Latest Patents: David Frendewey holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of innovations.

Career Highlights: With a career spanning over two decades, David Frendewey has consistently pushed the boundaries of traditional thinking, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, David Frendewey has collaborated with leading companies, research institutions, and universities to bring his ideas to life, fostering a culture of innovation and creativity.

Conclusion: David Frendewey's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors, leaving a lasting impact on the world of technology and beyond.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…